000 | 02145 a2200589 4500 | ||
---|---|---|---|
005 | 20250518065813.0 | ||
264 | 0 | _c20201201 | |
008 | 202012s 0 0 eng d | ||
022 | _a2055-6845 | ||
024 | 7 |
_a10.1093/ehjcvp/pvz061 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aNicolau, André M | |
245 | 0 | 0 |
_aEfficacy and safety of edoxaban compared with warfarin according to the burden of diseases in patients with atrial fibrillation: insights from the ENGAGE AF-TIMI 48 trial. _h[electronic resource] |
260 |
_bEuropean heart journal. Cardiovascular pharmacotherapy _c07 2020 |
||
300 |
_a167-175 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAnticoagulants _xadministration & dosage |
650 | 0 | 4 |
_aAtrial Fibrillation _xdiagnosis |
650 | 0 | 4 | _aComorbidity |
650 | 0 | 4 |
_aFactor Xa Inhibitors _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPyridines _xadministration & dosage |
650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
650 | 0 | 4 | _aRisk Assessment |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 |
_aStroke _xdiagnosis |
650 | 0 | 4 |
_aThiazoles _xadministration & dosage |
650 | 0 | 4 |
_aThromboembolism _xdiagnosis |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aWarfarin _xadministration & dosage |
700 | 1 | _aCorbalan, Ramon | |
700 | 1 | _aNicolau, Jose C | |
700 | 1 | _aRuff, Christian T | |
700 | 1 | _aZierhut, Wolfgang | |
700 | 1 | _aKerschnitzki, Michael | |
700 | 1 | _aDuris, Tibor | |
700 | 1 | _aJuul-Möller, Steen | |
700 | 1 | _aVoitk, Juri | |
700 | 1 | _aTrevisan, Marco | |
700 | 1 | _aNordio, Francesco | |
700 | 1 | _aAntman, Elliott M | |
700 | 1 | _aGiugliano, Robert P | |
773 | 0 |
_tEuropean heart journal. Cardiovascular pharmacotherapy _gvol. 6 _gno. 3 _gp. 167-175 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/ehjcvp/pvz061 _zAvailable from publisher's website |
999 |
_c30274482 _d30274482 |